Treatment of vitamin D deficiency/insufficiency with ergocalciferol is associated with reduced vascular access dysfunction in chronic hemodialysis patients

Gaurav Agarwal, Karina Vasquez, Neena Penagaluru, Jonathan A Gelfond, Wajeh Y Qunibi

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

Vitamin D deficiency or insufficiency is highly prevalent among patients with chronic kidney disease (CKD). This study aims to determine the relationship between vitamin D and frequency of vascular access dysfunction (VAD) in hemodialysis (HD) patients. We reviewed medical records of all HD patients who had serum 25-hydroxyvitamin D (25OHD) levels at 4 outpatient dialysis facilities between January 2011 and January 2012. Patients were included if they were ≥18 years of age, had been on maintenance dialysis for ≥3 months, and had native arteriovenous fistula or synthetic polytetrafluoroethylene grafts for dialysis access. Patients with catheters were excluded. 25-Hydroxyvitamin D levels

Original languageEnglish (US)
Pages (from-to)499-508
Number of pages10
JournalHemodialysis International
Volume19
Issue number4
DOIs
StatePublished - Oct 1 2015

Keywords

  • Access
  • Cardiovascular disease
  • Dialysis
  • Ergocalciferol
  • Vitamin D

ASJC Scopus subject areas

  • Hematology
  • Nephrology

Fingerprint Dive into the research topics of 'Treatment of vitamin D deficiency/insufficiency with ergocalciferol is associated with reduced vascular access dysfunction in chronic hemodialysis patients'. Together they form a unique fingerprint.

  • Cite this